Law360, New York ( July 15, 2011, 2:13 PM EDT) -- Federal laws governing the labeling of generic drugs preempt state law failure-to-warn claims against generic drug manufacturers, according to the U.S. Supreme Court's 5-4 opinion in Pliva Inc. v. Mensing, No. 09-993 on June 23, 2011....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.